Skip to main content

Evnin Luke

In the past year, 34 open-market sale filings worth $6.39M and no purchases.

Current role at each company

Show 1 more company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$6.39M
34 filings
Net
−$6.39M
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Evnin Luke as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TRDA Entrada Therapeutics, Inc.

10% Owner6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 9, 2026 (view filing)7:23 PM ETSep 4-95 daysGadicke Ansbert and 9 others10% OwnerSSale−259.8K$7.33−$1.91M−6.3%3.89M after3 lots
Sep 3, 2026 (view filing)7:21 PM ETSep 1-32 daysGadicke Ansbert and 9 others10% OwnerSSale−86.5K$7.14−$617.4K−2.0%4.14M after3 lots
Aug 31, 2026 (view filing)6:25 PM ETAug 27-314 daysGadicke Ansbert and 9 others10% OwnerSSale−86.9K$7.08−$615.8K−2.0%4.23M after3 lots
Aug 26, 2026 (view filing)9:28 PM ETAug 24-262 daysGadicke Ansbert and 9 others10% OwnerSSale−62.7K$7.36−$461.5K−1.4%4.32M after3 lotsDuplicate filing
Dec 12, 2024 (view filing)5:00 PM ETDec 10-112 daysGadicke Ansbert and 9 others10% OwnerSSale−44.7K$20.51−$917.1K−1.0%4.38M after2 lots
Nov 4, 2021 (view filing)5:37 PM ETNov 22 daysGadicke Ansbert and 8 others10% OwnerPPurchase+100.0K$20.00+$2.00M+2.3%4.43M afterDuplicate filing

HOWL Werewolf Therapeutics, Inc.

Director32 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 8, 2026 (view filing)5:34 PM ETJul 6-72 daysEvnin LukeDirectorSSale−143.2K$0.3125−$44.7K−100.0%0 after2 lots10b5-1
Jun 29, 2026 (view filing)7:07 PM ETJun 29Same dayEvnin LukeDirectorSSale−157.1K$0.30−$47.1K−52.3%143.2K after10b5-1
Jun 10, 2026 (view filing)5:20 PM ETJun 91 dayEvnin LukeDirectorSSale−76.9K$0.37−$28.5K−20.4%300.3K after10b5-1
Jun 8, 2026 (view filing)6:13 PM ETJun 4-84 daysEvnin LukeDirectorSSale−105.6K$0.4076−$43.0K−21.9%377.2K after3 lots10b5-1
Jun 3, 2026 (view filing)6:42 PM ETJun 1-32 daysEvnin LukeDirectorSSale−139.8K$0.4551−$63.6K−22.5%482.8K after3 lots10b5-1
May 29, 2026 (view filing)6:51 PM ETMay 27-292 daysEvnin LukeDirectorSSale−141.1K$0.4692−$66.2K−18.5%622.6K after3 lots10b5-1
May 26, 2026 (view filing)6:18 PM ETMay 21-265 daysEvnin LukeDirectorSSale−191.8K$0.4514−$86.6K−20.1%763.7K after3 lots10b5-1
May 20, 2026 (view filing)6:08 PM ETMay 18-202 daysEvnin LukeDirectorSSale−171.0K$0.4464−$76.4K−15.2%955.4K after3 lots10b5-1
May 13, 2026 (view filing)May 13Same dayEvnin LukeDirectorSSale−44.7K$0.54−$24.1K−3.8%1.13M after10b5-1
May 12, 2026 (view filing)May 8-124 daysEvnin LukeDirectorSSale−407.6K$0.6875−$280.2K−25.8%1.17M after3 lots10b5-1

See all 32 trades at HOWL

AKTS Aktis Oncology, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 14, 2026 (view filing)6:19 PM ETJan 122 daysEvnin Luke and 7 others10% OwnerPPurchase+1.11M$18.00+$20.0M+12.2%10.3M afterDuplicate filing

ITOS iTeos Therapeutics, Inc.

Other: Former 10% Owner17 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 15, 2025 (view filing)5:32 PM ETMay 132 daysEvnin Luke and 8 othersOther: Former 10% OwnerSSale−630.2K$8.06−$5.08M−23.0%2.11M after
Jan 6, 2022 (view filing)4:12 PM ETJan 4-52 daysEvnin Luke and 8 others10% OwnerSSale−146.7K$42.58−$6.25M−5.1%2.74M after5 lots
Dec 7, 2021 (view filing)6:35 PM ETDec 3-74 daysEvnin Luke and 8 others10% OwnerSSale−49.8K$33.73−$1.68M−1.7%2.89M after9 lots
Dec 2, 2021 (view filing)6:53 PM ETNov 30-Dec 22 daysEvnin Luke and 8 others10% OwnerSSale−83.5K$34.47−$2.88M−2.8%2.94M after7 lots
Nov 30, 2021 (view filing)4:53 PM ETNov 26-294 daysEvnin Luke and 8 others10% OwnerSSale−23.0K$35.18−$810.8K−0.8%3.02M after4 lots
Nov 24, 2021 (view filing)6:34 PM ETNov 22-242 daysEvnin Luke and 8 others10% OwnerSSale−77.5K$36.61−$2.84M−2.5%3.04M after7 lots
Oct 18, 2021 (view filing)4:34 PM ETOct 15-183 daysEvnin Luke and 8 others10% OwnerSSale−17.1K$27.45−$469.3K−0.5%3.13M after3 lots
Oct 14, 2021 (view filing)5:27 PM ETOct 12-142 daysEvnin Luke and 8 others10% OwnerSSale−56.8K$27.21−$1.54M−1.8%3.15M after3 lots
Oct 12, 2021 (view filing)4:34 PM ETOct 7-115 daysEvnin Luke and 8 others10% OwnerSSale−52.0K$27.23−$1.42M−1.6%3.21M after3 lots
Oct 5, 2021 (view filing)4:32 PM ETOct 1-44 daysEvnin Luke and 8 others10% OwnerSSale−27.6K$27.05−$745.5K−0.8%3.26M after2 lots

See all 17 trades at ITOS

TCRR TCR2 Therapeutics Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 24, 2023 (view filing)4:39 PM ETMay 222 daysEvnin Luke and 1 other10% OwnerSSale−70.2K$1.88−$131.9K−18.8%304.0K afterDuplicate filing